Editor's Note A shuttered bariatric surgery center in Oklahoma last month is just one example of how the rise of Glucagon-like peptide-1 (GLP-1) agonists are reshaping health systems’ investments, Axios reported August 13. Rather than “massive hospital towers with cardiology clinics, dialysis beds and joint replacement centers,” the focus is…

Read More

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

Editor's Note Bariatric surgery provides longer-lasting, more effective weight loss than GLP-1 receptor agonists and lifestyle interventions, according to systematic reviews of medical literature from 2020 to 2024. Medical Xpress reported the news June 11. Presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting,…

Read More

Editor's Note Bariatric surgery is more effective than lifestyle and medical interventions in glycemic control for Type 2 diabetes patients, according to findings published February 27 in JAMA. The clinical trial involved four health systems and 262 participants, 96 of whom received medical- and lifestyle-focused treatment and 166 of whom…

Read More

Editor's Note A new national survey by Cleveland Clinic finds a disconnect between men’s perception of their health and their actual health habits. A total of 1,000 US men, 18 years of age and older, were surveyed. In the survey, 81% of men said they believe they are leading a…

Read More